Intrasense - Asset Resilience Ratio
Intrasense (ALINS) has an Asset Resilience Ratio of 15.68% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Intrasense short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2023)
This chart shows how Intrasense's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Intrasense asset portfolio.
Liquid Assets Composition Over Time
This chart breaks down Intrasense's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore ALINS long-term investments to assets to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €1.44 Million | 15.68% |
| Short-term Investments | €0.00 | 0% |
| Total Liquid Assets | €1.44 Million | 15.68% |
Asset Resilience Insights
- Good Liquidity Position: Intrasense maintains a healthy 15.68% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Intrasense Industry Peers by Asset Resilience Ratio
Compare Intrasense's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
ARTRYA Ltd
AU:AYA |
Health Information Services | 32.70% |
|
Painchek Ltd
AU:PCK |
Health Information Services | 55.69% |
|
Trivarx Ltd
AU:TRI |
Health Information Services | 2.55% |
|
HITIQ Ltd
AU:HIQ |
Health Information Services | 30.25% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 54.64% |
|
Cogstate Ltd
AU:CGS |
Health Information Services | 54.90% |
|
Echoiq Ltd
AU:EIQ |
Health Information Services | 11.12% |
|
Oneview Healthcare Plc
AU:ONE |
Health Information Services | 29.71% |
Annual Asset Resilience Ratio for Intrasense (2008–2023)
The table below shows the annual Asset Resilience Ratio data for Intrasense.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 33.48% | €3.50 Million ≈ $4.09 Million |
€10.45 Million ≈ $12.22 Million |
+34.03pp |
| 2022-12-31 | -0.55% | €-36.00K ≈ $-42.09K |
€6.51 Million ≈ $7.61 Million |
-67.85pp |
| 2021-12-31 | 67.30% | €5.90 Million ≈ $6.90 Million |
€8.77 Million ≈ $10.25 Million |
+53.15pp |
| 2020-12-31 | 14.15% | €900.00K ≈ $1.05 Million |
€6.36 Million ≈ $7.44 Million |
+6.00pp |
| 2018-12-31 | 8.14% | €358.58K ≈ $419.22K |
€4.40 Million ≈ $5.15 Million |
-7.31pp |
| 2017-12-31 | 15.46% | €565.80K ≈ $661.48K |
€3.66 Million ≈ $4.28 Million |
+2.23pp |
| 2016-12-31 | 13.23% | €700.81K ≈ $819.32K |
€5.30 Million ≈ $6.19 Million |
-2.48pp |
| 2015-12-31 | 15.71% | €966.48K ≈ $1.13 Million |
€6.15 Million ≈ $7.19 Million |
+5.91pp |
| 2014-12-31 | 9.80% | €671.87K ≈ $785.49K |
€6.85 Million ≈ $8.01 Million |
-6.68pp |
| 2013-12-31 | 16.48% | €1.27 Million ≈ $1.48 Million |
€7.70 Million ≈ $9.00 Million |
-24.51pp |
| 2012-12-31 | 40.99% | €3.87 Million ≈ $4.53 Million |
€9.44 Million ≈ $11.04 Million |
+22.23pp |
| 2011-12-31 | 18.76% | €1.17 Million ≈ $1.37 Million |
€6.23 Million ≈ $7.28 Million |
-23.53pp |
| 2010-12-31 | 42.29% | €2.12 Million ≈ $2.48 Million |
€5.01 Million ≈ $5.86 Million |
-13.36pp |
| 2009-12-31 | 55.65% | €3.06 Million ≈ $3.58 Million |
€5.51 Million ≈ $6.44 Million |
-22.70pp |
| 2008-12-31 | 78.35% | €4.52 Million ≈ $5.28 Million |
€5.77 Million ≈ $6.74 Million |
-- |
About Intrasense
Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that… Read more